Smoked cannabis for chronic neuropathic pain: a randomized controlled trial.
BACKGROUND
Chronic neuropathic pain affects 1%-2% of the adult population and is often refractory to standard pharmacologic treatment. Patients with chronic pain have reported using smoked cannabis to relieve pain, improve sleep and improve mood.


METHODS
Adults with post-traumatic or postsurgical neuropathic pain were randomly assigned to receive cannabis at four potencies (0%, 2.5%, 6% and 9.4% tetrahydrocannabinol) over four 14-day periods in a crossover trial. Participants inhaled a single 25-mg dose through a pipe three times daily for the first five days in each cycle, followed by a nine-day washout period. Daily average pain intensity was measured using an 11-point numeric rating scale. We recorded effects on mood, sleep and quality of life, as well as adverse events.


RESULTS
We recruited 23 participants (mean age 45.4 [standard deviation 12.3] years, 12 women [52%]), of whom 21 completed the trial. The average daily pain intensity, measured on the 11-point numeric rating scale, was lower on the prespecified primary contrast of 9.4% v. 0% tetrahydrocannabinol (5.4 v. 6.1, respectively; difference = 0.7, 95% confidence interval [CI] 0.02-1.4). Preparations with intermediate potency yielded intermediate but nonsignificant degrees of relief. Participants receiving 9.4% tetrahydrocannabinol reported improved ability to fall asleep (easier, p = 0.001; faster, p < 0.001; more drowsy, p = 0.003) and improved quality of sleep (less wakefulness, p = 0.01) relative to 0% tetrahydrocannabinol. We found no differences in mood or quality of life. The most common drug-related adverse events during the period when participants received 9.4% tetrahydrocannabinol were headache, dry eyes, burning sensation in areas of neuropathic pain, dizziness, numbness and cough.


CONCLUSIONS
A single inhalation of 25 mg of 9.4% tetrahydrocannabinol herbal cannabis three times daily for five days reduced the intensity of pain, improved sleep and was well tolerated. Further long-term safety and efficacy studies are indicated. (International Standard Randomised Controlled Trial Register no. ISRCTN68314063).
Ware
Mark A
MA
Department of Anesthesia, McGill University, Montréal, Que. mark.ware@muhc.mcgill.ca
Wang
Tongtong
T
Shapiro
Stan
S
Robinson
Ann
A
Ducruet
Thierry
T
Huynh
Thao
T
Gamsa
Ann
A
Bennett
Gary J
GJ
Collet
Jean-Paul
JP
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D018592:Cross-Over Studies; D004311:Double-Blind Method; D013759:Dronabinol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008385:Marijuana Smoking; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy*; D010147:Pain Measurement; D010919:Placebos; D011788:Quality of Life; D012890:Sleep / Q000187:drug effects; D016896:Treatment Outcome
D010919:Placebos; D013759:Dronabinol
Br J Rheumatol. 1997 May;36(5):551-9
9189057
Pharmacol Biochem Behav. 1994 Nov;49(3):643-7
7862719
Pain Res Manag. 2002 Summer;7(2):95-9
12185373
Eur J Neurol. 2006 Nov;13(11):1153-69
17038030
Psychopharmacology (Berl). 1988;94(2):206-12
3127846
Pain Res Manag. 2007 Spring;12(1):13-21
17372630
Neurology. 2007 Feb 13;68(7):515-21
17296917
Clin Pharmacol Ther. 2007 Nov;82(5):572-8
17429350
Nature. 1998 Sep 24;395(6700):381-3
9759727
JAMA. 1998 Dec 2;280(21):1831-6
9846777
J Pain. 2008 Jun;9(6):506-21
18403272
J Pain. 2004 Apr;5(3):143-9
15106126
Rheumatology (Oxford). 2006 Jan;45(1):50-2
16282192
J Pain. 2008 Feb;9(2):164-73
17974490
N Engl J Med. 2003 Mar 27;348(13):1243-55
12660389
BMJ. 2004 Jul 31;329(7460):253
15258006
Pain. 2005 Jan;113(1-2):9-19
15621359
J Psychopharmacol. 2008 Sep;22(7):707-16
18515447
Neuropsychopharmacology. 2009 Feb;34(3):672-80
18688212
Psychopharmacology (Berl). 1992;107(2-3):255-62
1319601
Neurology. 2005 Sep 27;65(6):812-9
16186518
Neurology. 2004 Jun 8;62(11):2098-100
15184623
J Pain. 2008 Feb;9(2):105-21
18055266
J Pain. 2005 Apr;6(4):253-60
15820913
Clin Pharmacokinet. 2003;42(4):327-60
12648025
Pain. 2007 Dec 15;133(1-3):210-20
17997224
Psychopharmacology (Berl). 1980;71(2):173-9
6777817
J Pharmacol Exp Ther. 1992 Apr;261(1):114-22
1313866
Pain. 1987 Aug;30(2):191-197
3670870
Pain. 2003 Mar;102(1-2):211-6
12620613
J Pers Assess. 1983 Jun;47(3):305-6
6886962